Our Privacy Statement & Cookie Policy

By continuing to browse our site you agree to our use of cookies, revised Privacy Policy and Terms of Use. You can change your cookie settings through your browser.

I agree

Analyst: U.S. targeting Chinese biotech firms is a populist-driven 'hot and cold' strategy

02:45

China's Foreign Ministry is protesting a U.S. bill that targets several Chinese biotech companies and their US subsidiaries. The Biosecure Act seeks to ban a group of five biotechnology companies with Chinese ties from working with anyone who receives federal money. Einar Tangen, senior fellow at the Taihe Institute and Chairman of Asia Narratives, says China needs to prepare for more such actions. He adds that it's a "hot and cold" strategy pushed by populists politics, part of America's victimization narrative. 

Search Trends